Brianna Dollinger is an associate in Weil’s Mergers & Acquisitions practice and is based in New York. Ms. Dollinger participates in the representation of public and private companies in mergers, acquisitions and divestitures.
Ms. Dollinger has been part of the teams advising:
- American Gilsonite Company in its prepackaged chapter 11 cases.
- Brookfield Asset Management Inc. in its pending approximately $4.8 billion acquisition of a 62% stake in Oaktree Capital Group, LLC.
- Engility Holdings, Inc. in its $2.5 billion all-stock sale to Science Applications International Corp.
- Evercore as financial advisor to a committee of independent directors of T-Mobile US, Inc. in T-Mobile's $146 billion merger with Sprint Corporation.
- Gurnet Point Capital in its up to $504 million take-private of Corium International, Inc.
- PSAV, Goldman Sachs and Olympus Partners (PSAV’s sponsors) in the sale of PSAV to Blackstone.
- Sanofi in its up to $750 million acquisition of Protein Sciences Corporation.
- Scripps Networks Interactive, Inc. in its $14.6 billion merger with Discovery Communications, Inc.
- Takata Corporation in its $1.6 billion asset sale to Key Safety Systems Inc. through a chapter 11 plan.
- Tianqi Lithium Corporation in its $4.07 billion acquisition of approximately 63 million A Shares of Sociedad Química y Minera de Chile S.A.
- York Capital Management, Valinor Management and Halcyon Capital Management, principal equity owners of NextDecade, LLC, in the $1 billion reverse merger of NextDecade with SPAC Harmony Merger Corp.
Ms. Dollinger received her J.D. from Harvard Law School and her B.A. from Cornell University.